• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年囊性纤维化患者的骨矿物质密度和身体成分

Bone mineral density and body composition in adult patients with cystic fibrosis.

作者信息

Grey A B, Ames R W, Matthews R D, Reid I R

机构信息

Department of Medicine, University of Auckland, New Zealand.

出版信息

Thorax. 1993 Jun;48(6):589-93. doi: 10.1136/thx.48.6.589.

DOI:10.1136/thx.48.6.589
PMID:8346485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC464571/
Abstract

BACKGROUND

Cystic fibrosis is a multisystem disease characterised by chronic pulmonary sepsis and malnutrition. To ascertain whether osteoporosis is a feature of cystic fibrosis in adult patients, total body and regional bone mineral density (BMD) was measured in a group of eight men and eight women aged 17-42 years.

METHODS

Total body and regional BMD (lumbar spine L2-L4, femoral neck, trochanteric, and Ward's triangle), as well as total body fat and lean mass, were measured by dual energy x ray absorptiometry. A range of biochemical, lifestyle, and anthropometric variables was also assessed.

RESULTS

Patients with cystic fibrosis had significantly reduced bone density at all sites compared with normal young adults. The mean reductions ranged from 7% at Ward's triangle to 13% at the trochanter. Body mass index (BMI) was positively correlated with BMD at four sites and disease severity negatively correlated with BMD at two sites. Other biochemical and anthropometric variables were not predictive of bone density. Total body fat mass was reduced by 30% compared with normal young adults.

CONCLUSIONS

Bone density is decreased in adult patients with cystic fibrosis and BMI and disease severity are independent predictors of bone density.

摘要

背景

囊性纤维化是一种多系统疾病,其特征为慢性肺脓毒症和营养不良。为确定骨质疏松是否为成年囊性纤维化患者的一个特征,对一组年龄在17至42岁的8名男性和8名女性进行了全身和局部骨矿物质密度(BMD)测量。

方法

采用双能X线吸收法测量全身和局部BMD(腰椎L2-L4、股骨颈、大转子和沃德三角区),以及全身脂肪和瘦体重。还评估了一系列生化、生活方式和人体测量学变量。

结果

与正常年轻成年人相比,囊性纤维化患者所有部位的骨密度均显著降低。平均降低幅度从沃德三角区的7%到转子区的13%不等。体重指数(BMI)与四个部位的BMD呈正相关,疾病严重程度与两个部位的BMD呈负相关。其他生化和人体测量学变量不能预测骨密度。与正常年轻成年人相比,全身脂肪量减少了30%。

结论

成年囊性纤维化患者骨密度降低,BMI和疾病严重程度是骨密度的独立预测因素。

相似文献

1
Bone mineral density and body composition in adult patients with cystic fibrosis.成年囊性纤维化患者的骨矿物质密度和身体成分
Thorax. 1993 Jun;48(6):589-93. doi: 10.1136/thx.48.6.589.
2
Osteopenia in adults with cystic fibrosis.成年囊性纤维化患者的骨质减少
Am J Med. 1994 Jan;96(1):27-34. doi: 10.1016/0002-9343(94)90112-0.
3
Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.晚期囊性纤维化肺病成人患者的骨量与维生素D缺乏
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1892-9. doi: 10.1164/ajrccm.157.6.9712089.
4
Correlates of osteopenia in patients with cystic fibrosis.囊性纤维化患者骨质减少的相关因素
Pediatrics. 1996 Jan;97(1):103-11.
5
Influence of basal energy expenditure and body composition on bone mineral density in postmenopausal women.绝经后妇女基础能量消耗和身体成分对骨密度的影响。
Int J Gen Med. 2012;5:909-15. doi: 10.2147/IJGM.S36823. Epub 2012 Nov 5.
6
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.终末期肺病肺移植候选者中的骨质疏松症
Am J Med. 1996 Sep;101(3):262-9. doi: 10.1016/S0002-9343(96)00155-6.
7
Determinants of bone mass in 10- to 26-year-old females: a twin study.10至26岁女性骨量的决定因素:一项双胞胎研究。
J Bone Miner Res. 1995 Apr;10(4):558-67. doi: 10.1002/jbmr.5650100408.
8
Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women.膳食中的钙、蛋白质和磷与年轻女性的骨矿物质密度及含量有关。
Am J Clin Nutr. 1998 Sep;68(3):749-54. doi: 10.1093/ajcn/68.3.749.
9
Relative contribution of body composition to bone mineral density at different sites in men and women of South Korea.韩国男性和女性身体成分对不同部位骨密度的相对贡献。
J Bone Miner Metab. 2007;25(3):165-71. doi: 10.1007/s00774-006-0747-3. Epub 2007 Apr 20.
10
Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis.新的稳定同位素技术评估发现,全身羟脯氨酸生成增加与囊性纤维化的髋部和脊柱骨矿物质丢失有关。
Clin Nutr. 2014 Dec;33(6):1117-21. doi: 10.1016/j.clnu.2013.12.008. Epub 2013 Dec 29.

引用本文的文献

1
Cystic fibrosis-related bone disease: an update on screening, diagnosis, and treatment.囊性纤维化相关骨病:筛查、诊断及治疗的最新进展
Ther Adv Endocrinol Metab. 2025 Apr 2;16:20420188251328210. doi: 10.1177/20420188251328210. eCollection 2025.
2
Vasoactive intestinal peptide and cystic fibrosis transmembrane conductance regulator contribute to the transepithelial calcium transport across intestinal epithelium-like Caco-2 monolayer.血管活性肠肽和囊性纤维化跨膜电导调节因子促进肠上皮样 Caco-2 单层细胞的跨上皮钙转运。
PLoS One. 2022 Nov 18;17(11):e0277096. doi: 10.1371/journal.pone.0277096. eCollection 2022.
3
An update on methods for assessing bone quality and health in Cystic fibrosis.囊性纤维化患者骨质量与健康评估方法的最新进展
J Clin Transl Endocrinol. 2021 Dec 6;27:100281. doi: 10.1016/j.jcte.2021.100281. eCollection 2022 Mar.
4
Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.囊性纤维化和终末期肺病患者的骨病评估
J Bras Pneumol. 2019 Feb 28;45(1):e20170280. doi: 10.1590/1806-3713/e20170280.
5
Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients.肺移植术后囊性纤维化患者支气管镜检查时使用丙泊酚镇静。
Lung. 2018 Aug;196(4):435-439. doi: 10.1007/s00408-018-0119-5. Epub 2018 May 24.
6
Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period.15年间囊性纤维化年轻成人骨矿物质密度的变化趋势
J Cyst Fibros. 2015 Jul;14(4):526-32. doi: 10.1016/j.jcf.2015.01.011. Epub 2015 Feb 16.
7
Factors associated with low bone mineral density in patients with cystic fibrosis.囊性纤维化患者骨矿物质密度低的相关因素。
J Bone Miner Metab. 2015 Mar;33(2):180-5. doi: 10.1007/s00774-014-0572-z. Epub 2014 Mar 16.
8
Bone mineral density among elderly patients with chronic obstructive pulmonary disease patients in India.印度慢性阻塞性肺疾病老年患者的骨矿物质密度
Niger Med J. 2013 Sep;54(5):295-301. doi: 10.4103/0300-1652.122329.
9
Hypervitaminosis D: case report of pediatric osteoporosis secondary to cystic fibrosis.维生素D过多症:继发于囊性纤维化的小儿骨质疏松症病例报告。
Clin Cases Miner Bone Metab. 2011 Sep;8(3):66-8.
10
Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients.乳糖吸收不良是胰腺功能不全囊性纤维化患者骨密度降低的一个风险因素。
Eur J Hum Genet. 2012 Oct;20(10):1092-5. doi: 10.1038/ejhg.2012.52. Epub 2012 Mar 28.

本文引用的文献

1
Some biochemical indices of nutrition in treated cystic fibrosis patients.接受治疗的囊性纤维化患者的一些营养生化指标。
Am J Clin Nutr. 1981 Apr;34(4):462-74. doi: 10.1093/ajcn/34.4.462.
2
Testosterone and bone loss in Klinefelter syndrome.克兰费尔特综合征中的睾酮与骨质流失
Horm Metab Res. 1983 Jan;15(1):56-7. doi: 10.1055/s-2007-1018630.
3
Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment.患有囊性纤维化的男性青少年身材矮小和青春期延迟。雄激素治疗。
Am J Dis Child. 1984 Apr;138(4):388-91. doi: 10.1001/archpedi.1984.02140420054017.
4
Decreased spinal mineral content in amenorrheic women.闭经女性脊柱矿物质含量降低。
JAMA. 1984 Feb 3;251(5):626-9.
5
Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis.
J Pediatr. 1983 Oct;103(4):538-42. doi: 10.1016/s0022-3476(83)80579-4.
6
A new prognostic score and clinical evaluation system for cystic fibrosis.一种用于囊性纤维化的新预后评分及临床评估系统。
J Pediatr. 1973 Mar;82(3):380-90. doi: 10.1016/s0022-3476(73)80110-6.
7
Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis.患有囊性纤维化的年轻成年人的临床特征、生存率及预后因素
Am J Med. 1987 May;82(5):871-9. doi: 10.1016/0002-9343(87)90147-1.
8
Osteoporosis in cystic fibrosis.
J Pediatr. 1988 Aug;113(2):295-300. doi: 10.1016/s0022-3476(88)80268-3.
9
Lifetime fracture risk: an approach to hip fracture risk assessment based on bone mineral density and age.终生骨折风险:一种基于骨密度和年龄的髋部骨折风险评估方法。
J Clin Epidemiol. 1988;41(10):985-94. doi: 10.1016/0895-4356(88)90036-4.
10
Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures.
Endocrinology. 1987 Jun;120(6):2494-9. doi: 10.1210/endo-120-6-2494.